 ERYTECH Pharma Euronext: ERYP - Nasdaq: ERYP, a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced that it has entered into a strategic partnership with the German Red Cross Blood Donor Service Baden-Württemberg-Hessen GRCBDS to complement the existing alliance with the French Blood bank EFS for the supply of donor red blood cells to manufacture its product candidates, including eryaspase, in Europe. The GRCBDS is one of the worlds largest blood and transfusion services, ensuring safe and adequate supply of blood products for approximately 30 million Germans more than one-third of the German population. 